This week, Beyond Biotech examined how Diagonal Therapeutics is applying clustering antibodies to address vascular diseases, a therapeutic approach that challenges conventional thinking about antibody design. The episode highlights an emerging tension in biotech between incremental refinements of existing modalities and more fundamental reimagining of how proteins can be engineered to solve clinical problems.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top beyond biotech podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Other Weeks
This Week in Beyond Biotech (Jun 8 - Jun 14, 2026)
1 episode · Jun 8 – Jun 14
This Week in Beyond Biotech (Jun 1 - Jun 7, 2026)
1 episode · Jun 1 – Jun 7
This Week in Beyond Biotech (May 18 - May 24, 2026)
1 episode · May 18 – May 24
This Week in Beyond Biotech (May 11 - May 17, 2026)
1 episode · May 11 – May 17
This Week in Beyond Biotech (May 4 - May 10, 2026)
1 episode · May 4 – May 10
This Week in Beyond Biotech (Apr 27 - May 3, 2026)
1 episode · Apr 27 – May 3
This Week in Beyond Biotech (Apr 13 - Apr 19, 2026)
1 episode · Apr 13 – Apr 19
This Week in Beyond Biotech (Apr 6 - Apr 12, 2026)
1 episode · Apr 6 – Apr 12
This Week in Beyond Biotech (Mar 30 - Apr 5, 2026)
1 episode · Mar 30 – Apr 5
This Week in Beyond Biotech (Mar 23 - Mar 29, 2026)
1 episode · Mar 23 – Mar 29